• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素 2 型受体的脂质信号转导是否是保护系统的一部分?

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

机构信息

Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892-9413, USA.

出版信息

Prog Lipid Res. 2011 Apr;50(2):193-211. doi: 10.1016/j.plipres.2011.01.001. Epub 2011 Feb 2.

DOI:10.1016/j.plipres.2011.01.001
PMID:21295074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3062638/
Abstract

The mammalian body has a highly developed immune system which guards against continuous invading protein attacks and aims at preventing, attenuating or repairing the inflicted damage. It is conceivable that through evolution analogous biological protective systems have been evolved against non-protein attacks. There is emerging evidence that lipid endocannabinoid signaling through cannabinoid 2 (CB₂) receptors may represent an example/part of such a protective system/armamentarium. Inflammation/tissue injury triggers rapid elevations in local endocannabinoid levels, which in turn regulate signaling responses in immune and other cells modulating their critical functions. Changes in endocannabinoid levels and/or CB₂ receptor expressions have been reported in almost all diseases affecting humans, ranging from cardiovascular, gastrointestinal, liver, kidney, neurodegenerative, psychiatric, bone, skin, autoimmune, lung disorders to pain and cancer, and modulating CB₂ receptor activity holds tremendous therapeutic potential in these pathologies. While CB₂ receptor activation in general mediates immunosuppressive effects, which limit inflammation and associated tissue injury in large number of pathological conditions, in some disease states activation of the CB₂ receptor may enhance or even trigger tissue damage, which will also be discussed alongside the protective actions of the CB₂ receptor stimulation with endocannabinoids or synthetic agonists, and the possible biological mechanisms involved in these effects.

摘要

哺乳动物的身体具有高度发达的免疫系统,可以抵御持续的入侵蛋白质攻击,并旨在预防、减轻或修复所造成的损伤。可以想象,通过进化,针对非蛋白质攻击也已经进化出类似的生物保护系统。有新的证据表明,通过大麻素 2(CB₂)受体的脂质内源性大麻素信号可能代表这种保护系统/武器库的一个例子/部分。炎症/组织损伤会迅速引起局部内源性大麻素水平升高,反过来又会调节免疫和其他细胞中的信号反应,调节它们的关键功能。在影响人类的几乎所有疾病中,包括心血管、胃肠道、肝脏、肾脏、神经退行性、精神、骨骼、皮肤、自身免疫、肺部疾病到疼痛和癌症,都报告了内源性大麻素水平和/或 CB₂ 受体表达的变化,调节 CB₂ 受体活性在这些病理中具有巨大的治疗潜力。虽然 CB₂ 受体的激活通常介导免疫抑制作用,从而限制了大量病理条件下的炎症和相关组织损伤,但在某些疾病状态下,CB₂ 受体的激活可能会增强甚至引发组织损伤,这也将与内源性大麻素或合成激动剂对 CB₂ 受体刺激的保护作用以及这些作用涉及的可能生物学机制一起进行讨论。

相似文献

1
Is lipid signaling through cannabinoid 2 receptors part of a protective system?大麻素 2 型受体的脂质信号转导是否是保护系统的一部分?
Prog Lipid Res. 2011 Apr;50(2):193-211. doi: 10.1016/j.plipres.2011.01.001. Epub 2011 Feb 2.
2
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.靶向CB2受体和内源性大麻素系统治疗疼痛。
Brain Res Rev. 2009 Apr;60(1):255-66. doi: 10.1016/j.brainresrev.2008.12.003. Epub 2008 Dec 25.
3
Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain.内源性大麻素、星形胶质细胞和 p38 磷酸化在术后疼痛缓解中的作用证据。
PLoS One. 2010 May 28;5(5):e10891. doi: 10.1371/journal.pone.0010891.
4
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.靶向大麻素受体或调节内源性大麻素组织水平或作用的药物的治疗潜力。
AAPS J. 2005 Oct 24;7(3):E625-54. doi: 10.1208/aapsj070364.
5
The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings.内源性大麻素系统作为肝脏疾病中的关键介质:新的见解和治疗新途径。
Br J Pharmacol. 2011 Aug;163(7):1432-40. doi: 10.1111/j.1476-5381.2011.01397.x.
6
The endocannabinoid system in Huntington's disease.亨廷顿舞蹈病中的内源性大麻素系统。
Curr Pharm Des. 2008;14(23):2317-25. doi: 10.2174/138161208785740108.
7
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.脂筏对人免疫细胞中Cb2受体信号传导及2-花生四烯酸甘油代谢的影响。
J Immunol. 2006 Oct 15;177(8):4971-80. doi: 10.4049/jimmunol.177.8.4971.
8
Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.粒细胞集落刺激因子增强创伤性脑损伤后的脑修复,而无需激活大麻素受体。
Cannabis Cannabinoid Res. 2021 Feb 12;6(1):48-57. doi: 10.1089/can.2019.0090. eCollection 2021.
9
Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.大麻素受体 2 及其激动剂可调节造血以及造血干细胞和祖细胞的动员。
Blood. 2011 Jan 20;117(3):827-38. doi: 10.1182/blood-2010-01-265082. Epub 2010 Nov 9.
10
Endocannabinoids and Their Pharmacological Actions.内源性大麻素及其药理作用。
Handb Exp Pharmacol. 2015;231:1-37. doi: 10.1007/978-3-319-20825-1_1.

引用本文的文献

1
Reframing type 1 diabetes through the endocannabinoidome-microbiota axis: a systems biology perspective.从内源性大麻素组-微生物群轴重新审视1型糖尿病:系统生物学视角
Front Endocrinol (Lausanne). 2025 May 29;16:1576419. doi: 10.3389/fendo.2025.1576419. eCollection 2025.
2
Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells.大麻素受体2选择性激动剂通过调节调节性T细胞和辅助性T细胞17之间的平衡来改善佐剂诱导的关节炎。
Front Pharmacol. 2025 Jan 31;16:1532518. doi: 10.3389/fphar.2025.1532518. eCollection 2025.
3
Cannabis sativa extracts inhibit LDL oxidation and the formation of foam cells in vitro, acting as potential multi-step inhibitors of atherosclerosis development.

本文引用的文献

1
Endocannabinoids in liver disease.内源性大麻素在肝脏疾病中的作用。
Hepatology. 2011 Jan;53(1):346-55. doi: 10.1002/hep.24077.
2
The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy.内香草素/内源性大麻素系统:骨质疏松症治疗的新潜在靶点。
Bone. 2011 May 1;48(5):997-1007. doi: 10.1016/j.bone.2011.01.001. Epub 2011 Jan 13.
3
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.GPR55 在酵母中的药理学及 GSK494581A 作为混合活性甘氨酸转运体亚型 1 抑制剂和 GPR55 激动剂的鉴定。
大麻提取物在体外可抑制低密度脂蛋白氧化和泡沫细胞形成,作为动脉粥样硬化发展的潜在多步骤抑制剂。
PLoS One. 2024 Dec 20;19(12):e0310777. doi: 10.1371/journal.pone.0310777. eCollection 2024.
4
The cannabinoid CB agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats.大麻素CB激动剂LY2828360可抑制大鼠的神经性疼痛行为,并减轻吗啡耐受性和条件性位置偏爱。
Neuropharmacology. 2025 Mar 1;265:110257. doi: 10.1016/j.neuropharm.2024.110257. Epub 2024 Dec 5.
5
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for Studies.一种用于研究的高效、口服生物利用度高的吡唑衍生大麻素CB2受体选择性完全激动剂。
ACS Pharmacol Transl Sci. 2024 Jul 9;7(8):2424-2438. doi: 10.1021/acsptsci.4c00269. eCollection 2024 Aug 9.
6
Effect of EMB-FUBINACA on brain endothelial cell angiogenesis: Expression analysis of angiogenic markers.依替米星-富马酸福莫特罗对脑内皮细胞血管生成的影响:血管生成标志物的表达分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1613-1624. doi: 10.1007/s00210-024-03322-1. Epub 2024 Aug 13.
7
Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection.大麻素对病毒感染的免疫调节作用:对其在SARS-CoV2感染中潜在用途的综述
Virusdisease. 2024 Jun;35(2):342-356. doi: 10.1007/s13337-024-00871-0. Epub 2024 May 27.
8
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.RG7774(维卡西纳宾)是一种口服生物利用度良好的大麻素受体2(CB2R)激动剂,可降低动物模型中的视网膜血管通透性、白细胞黏附及眼部炎症。
Front Pharmacol. 2024 Jul 12;15:1426446. doi: 10.3389/fphar.2024.1426446. eCollection 2024.
9
In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities.深入探讨:大麻的全面综述;其化学复杂性、生物合成及治疗能力
Toxicol Rep. 2024 Jun 29;13:101685. doi: 10.1016/j.toxrep.2024.101685. eCollection 2024 Dec.
10
The development status of PET radiotracers for evaluating neuroinflammation.用于评估神经炎症的正电子发射断层显像(PET)放射性示踪剂的发展现状。
Nucl Med Mol Imaging. 2024 Jun;58(4):160-176. doi: 10.1007/s13139-023-00831-4. Epub 2024 Jan 8.
J Pharmacol Exp Ther. 2011 Apr;337(1):236-46. doi: 10.1124/jpet.110.172650. Epub 2011 Jan 13.
4
The manifold actions of endocannabinoids on female and male reproductive events.内源性大麻素对女性和男性生殖事件的多种作用。
Front Biosci (Landmark Ed). 2011 Jan 1;16(2):498-516. doi: 10.2741/3701.
5
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.基于三维定量构效关系分析的大麻素受体 2 高选择性配体的合理设计。
Eur J Med Chem. 2011 Feb;46(2):547-55. doi: 10.1016/j.ejmech.2010.11.034. Epub 2010 Nov 27.
6
Anandamide serves two masters in the brain.花生四烯乙醇胺在大脑中扮演着两种角色。
Nat Neurosci. 2010 Dec;13(12):1446-8. doi: 10.1038/nn1210-1446.
7
Expression and function of cannabinoid receptors in mouse islets.大麻素受体在小鼠胰岛中的表达和功能。
Islets. 2010 Sep-Oct;2(5):293-302. doi: 10.4161/isl.2.5.12729. Epub 2010 Sep 1.
8
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.国际基础和临床药理学联合会. LXXIX. 大麻素受体及其配体:超越 CB₁ 和 CB₂。
Pharmacol Rev. 2010 Dec;62(4):588-631. doi: 10.1124/pr.110.003004.
9
Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens.突触后 TRPV1 在伏隔核中触发细胞类型特异性的长时程抑郁。
Nat Neurosci. 2010 Dec;13(12):1519-25. doi: 10.1038/nn.2685. Epub 2010 Nov 14.
10
TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus.内源性大麻素通过 TRPV1 激活触发齿状回突触后长时程抑制。
Nat Neurosci. 2010 Dec;13(12):1511-8. doi: 10.1038/nn.2684. Epub 2010 Nov 14.